Participant satisfaction with fecal occult blood test screening for colorectal cancer [3]

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 1, 2007, Pages 142-143

  Worthley, Daniel L ^a,b   Cole, Stephen R ^a,b   Mehaffey, Sarah ^a   Roosa, Naomi M ^c   Smith, Alicia ^b   Turnbull, Deborah ^c   Young, Graeme P ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COLORECTAL CANCER; FECES ANALYSIS; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; LETTER; OCCULT BLOOD TEST; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SAMPLING;

EID: 33845603094     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04349.x     Document Type: Letter

References (3)

1. National Health and Medical Research Council Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Canberra: National Health and Medical Research Council, 1999.
2. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med. 1993; 328: 1365-71.
3. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J. Med. Screen. 2003; 10: 117-22.